Assessing the Usefulness of the Prevexair Smartphone Applicationin the Follow-Up High-Risk Patients with COPD

dc.contributor.authorRodríguez Hermosa, Juan Luis
dc.contributor.authorFuster Gomila A
dc.contributor.authorPuente Maestu, Luis
dc.contributor.authorAmado Diago CA
dc.contributor.authorCallejas González FJ
dc.contributor.authorMalo De Molina Ruiz R
dc.contributor.authorFuentes Ferrer ME
dc.contributor.authorÁlvarez-Sala Walther, José Luis
dc.contributor.authorCalle Rubio M
dc.date.accessioned2026-01-12T11:37:57Z
dc.date.available2026-01-12T11:37:57Z
dc.date.issued2021
dc.description.abstractIntroduction: This manuscript analyzes the exacerbations recorded by the Prevexair application through the daily analysis of symptoms in high-risk patients with COPD and explores its usefulness in assessing clinical stability with respect to that reported in visits. Patients and Methods: This study is a multi-centre cohort of COPD patients with the exacerbator phenotype who were monitored over 6 months. The Prevexair application was installed on the patients’ smartphones. Patients used the app to record symptom changes, use of medication and use of healthcare resources. It is not established a recommended action plan when worsening of symptoms. At their clinical visit during the follow-up period, patients were asked about exacerbations suffered during these 6 months of monitoring. The investigators who conducted the visit were blinded about the Prevexair app records. Results: The patients experienced a total of 185 exacerbations according to daily records in the app whereas only 64 exacerbations were recalled during medical visits. Perception became more accurate for severe exacerbations (kappa 0.6577), although we found no factors that predicted poor recall. The proportion of 72.5% patients were classified as unstable if the exacerbations captured by Prevexair were used to define stability, versus 47.8% if the exacerbations recall in visit was used. Two-thirds of the exacerbations recorded in the Prevexair application were not reported to doctors during their clinical visits. Almost half were treated with oral corticosteroids and/or antibiotics and more than one-quarter of the exacerbations treated did not seek medical attention. Conclusion: The findings of this cohort study confirm that patients do not always remember the exacerbations suffered during their medical visit. The prevexair application is useful in monitoring COPD patients at high risk, in order to a better assessment of exacerbations of COPD during medical visits. Further research must be carried out to evaluate this strategy in clinical practice. Keywords: chronic obstructive pulmonary disease, telemonitoring, mobile health, exacerbations, clinical prediction, management, electronic patient record
dc.description.departmentDepto. de Medicina
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.citationRodríguez Hermosa, J. L., Fuster Gomila, A., Puente Maestu, L., Amado Diago, C. A., Callejas-González, F. J., Malo De Molina Ruiz, R., Fuentes Ferrer, M. E., Alvarez-Sala, J. L., & Calle Rubio, M. (2021). Assessing the usefulness of the prevexair smartphone application in the follow-up high-risk patients with copd. International Journal of Chronic Obstructive Pulmonary Disease, Volume 16, 53-65. https://doi.org/10.2147/COPD.S279394
dc.identifier.doi10.2147/COPD.S279394
dc.identifier.officialurlhttps://doi.org/10.2147/COPD.S279394
dc.identifier.relatedurlhttps://www.dovepress.com/assessing-the-usefulness-of-the-prevexair-smartphone-application-in-th-peer-reviewed-fulltext-article-COPD
dc.identifier.urihttps://hdl.handle.net/20.500.14352/129875
dc.journal.titleInternational Journal of Chronic Obstructive Pulmonary Disease
dc.language.isoeng
dc.page.final65
dc.page.initial53
dc.publisherDovepress
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.keywordChronic obstructive pulmonary disease
dc.subject.keywordMobile health
dc.subject.keywordExacerbations
dc.subject.keywordClinical prediction
dc.subject.keywordManagement
dc.subject.keywordElectronic patient record
dc.subject.keywordElectronic patient record
dc.subject.ucmNeumología
dc.subject.unesco3205.08 Enfermedades Pulmonares
dc.titleAssessing the Usefulness of the Prevexair Smartphone Applicationin the Follow-Up High-Risk Patients with COPD
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number16
dspace.entity.typePublication
relation.isAuthorOfPublication3337a5ba-7b25-4df3-a451-922ebb41e974
relation.isAuthorOfPublicationfc402859-256f-4320-bc14-03d02c24ff61
relation.isAuthorOfPublication15960888-3480-489d-9077-a4b564356caa
relation.isAuthorOfPublication.latestForDiscovery3337a5ba-7b25-4df3-a451-922ebb41e974

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
assessing-the-usefulness-of-the-prevexair-smartphone-applica.pdf
Size:
1.02 MB
Format:
Adobe Portable Document Format

Collections